Send to

Choose Destination
See comment in PubMed Commons below
Indian J Surg. 2012 Apr;74(2):157-62. doi: 10.1007/s12262-011-0407-2. Epub 2012 Jan 13.

Thrombophilia - how far and how much to investigate?

Author information

  • 1Department of Vascular surgery, Nizam's Institute of Medical Sciences, Panjagutta, Hyderabad, AP India 500082.


Thrombohemorrhagic balance is maintained by complicated interactions between the coagulation and fibrinolytic system, platelets, and the vessel wall. Dr. Virchow provided approach for investigating and managing thrombotic disorders. He proposed stasis, vascular injury, and hypercoagulability as causes for thrombosis. In 1965, antithrombin deficiency was described. After two decades, protein C and protein S deficiencies, mutations of factor V Leiden, and factor II were described. If we distinguish patients at high risk and low risk of thrombosis, we can optimize therapeutic decisions. There is currently no evidence to say that laboratory abnormality should influence intensity of anticoagulation. In this article we reviewed the risk factors and need for thrombophilia screening in patients. Screening general population for thrombophilia is not justified or recommended at this time.


Antiphospholipid antibody syndrome 8; Antithrombin 2; Factor V Leiden 5; Hyperhomocysteinemia 7; Protein C 3; Protein S 4; Prothrombin 6; Thromboembolism 9; Thrombophilia 1

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk